Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
Baek YY, Lee DK, Kim J, Kim JH, Park W, Kim T, Han S, Jeoung D, You JC, Lee H, Won MH, Ha KS, Kwon YG, Kim YM.
Baek YY, et al. Among authors: kim ym, kim t, kim j, kim jh.
Oncotarget. 2017 Feb 14;8(7):11763-11777. doi: 10.18632/oncotarget.14343.
Oncotarget. 2017.
PMID: 28052029
Free PMC article.